{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:00:35Z","timestamp":1648548035013},"reference-count":23,"publisher":"American Society of Consultant Pharmacists","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.4140\/tcp.n.2011.190","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T13:22:53Z","timestamp":1300195373000},"page":"190-196","source":"Crossref","is-referenced-by-count":0,"title":["Multiple-System Atrophy and Medications: How to Minimize the Risk of Falling"],"prefix":"10.4140","volume":"26","author":[{"given":"Janet","family":"Kohli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Brandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2011,3,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"N Stefanova","year":"2009","journal-title":"Lancet Neurol"},{"key":"2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology","volume":"8","author":"S Gilman","year":"1998","journal-title":"Clin Auton Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"S Gilman","year":"2008","journal-title":"Neurology"},{"key":"4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"GK Wenning","year":"2004","journal-title":"Mov Disord"},{"key":"5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/NRL.0b013e318167b93f","article-title":"Multiple system atrophy","volume":"14","author":"R Bhidayasiri","year":"2008","journal-title":"Neurologist"},{"key":"6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"MG Spillantini","year":"1998","journal-title":"Neurosci Lett"},{"key":"7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"K Wakabayashi","year":"1998","journal-title":"Neurosci Lett"},{"key":"8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/nen.0b013e3181587d64","article-title":"Protein aggregation mechanisms in synucleinopathies: commonalities and differences","volume":"66","author":"K Beyer","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.1995.00540270090024","article-title":"Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease","volume":"52","author":"C Colosimo","year":"1995","journal-title":"Arch Neurol"},{"key":"10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/jnnp.59.2.144","article-title":"Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria","volume":"59","author":"A Albanese","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00702-007-0746-0","article-title":"Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease","volume":"114","author":"U Wullner","year":"2007","journal-title":"J Neural Transm"},{"key":"12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archneurol.2009.71","article-title":"Prospective differentiation of multiple system atrophy from Parkinson's disease, with and without autonomic failure","volume":"66","author":"A Lipp","year":"2009","journal-title":"Arch Neurol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.277.13.1046","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"PA Low","year":"1997","journal-title":"JAMA"},{"key":"14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine","volume":"95","author":"J Jankovic","year":"1993","journal-title":"Am J Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mds.20867","article-title":"Bladder dysfunction in parkinsonism: mechanisms, prevalence, symptoms, and management","volume":"21","author":"K Winge","year":"2006","journal-title":"Mov Disord"},{"key":"16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/mds.20815","article-title":"Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?","volume":"21","author":"T Ito","year":"2006","journal-title":"Mov Disord"},{"key":"17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-1838(99)00105-8","article-title":"Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte","volume":"79","author":"R Sakakibara","year":"2000","journal-title":"J Auton Nerv Syst"},{"key":"18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1468-1331.2002.00348.x","article-title":"The symptomatic treatment of multiple system atrophy","volume":"9","author":"C Colosimo","year":"2002","journal-title":"Eur J Neurol"},{"key":"19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"IF Hussain","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/mds.21578","article-title":"Levodopa responsiveness in disorders with parkinsonism: a review of the literature","volume":"22","author":"R Constantinescu","year":"2007","journal-title":"Mov Disord"},{"key":"21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/brain\/awn291","article-title":"Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study","volume":"132","author":"G Bensimon","year":"2009","journal-title":"Brain"},{"key":"22","unstructured":"Drugs that cause orthostatic hypotension. Prescriber's Letter 2004;11: 200710."},{"key":"23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","article-title":"Management of neurogenic orthostatic hypotension: an update","volume":"7","author":"PA Low","year":"2008","journal-title":"Lancet Neurol"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T07:36:13Z","timestamp":1560065773000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2011\/00000026\/00000003\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3,1]]}},"alternative-id":["E238321653523656"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2011.190","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}